NCT02744703View on ClinicalTrials.gov

Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlled Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Matrix Metalloproteinase InhibitorsComposite Resins
Interventions
DRUG

total-etch adhesive

comparator use of total-etch adhesive

DRUG

CAPE-T

experimental group

DRUG

self-etch adhesive

comparator use of total-etch adhesive

DRUG

CAPE-S

experimental group

All Listed Sponsors
lead

Ege University

OTHER

NCT02744703 - Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlled Clinical Trial | Biotech Hunter | Biotech Hunter